national center on time & learning, inc.

24 school street, suite 301
boston, massachusetts 02018

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 07, 2013

NYS DOS ID#
4484126

County
MONROE

Jurisdiction
MASSACHUSETTS

Registered Agent
NONE

NYS Entity Type
FOREIGN NOT-FOR-PROFIT CORPORATION

Name History
2013 - NATIONAL CENTER ON TIME & LEARNING, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Robot Reshuffle: Alphabet Sells Boston Dynamics & Schaft to SoftBank
    By Gregory T. Huang - Friday Jun 9, 2017

    In a deal that was a long time coming, Google’s parent company Alphabet has sold robotics firms Boston Dynamics and Schaft to Japanese tech giant SoftBank. Terms of the deal were not disclosed. Boston Dynamics was rumored to be on the market for the past year, with potential suitors including Toyota and Amazon. The robotics […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Monday Jun 19, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Localytics Replaces Founding CEO After Becoming Cash-Flow Positive
    By Jeff Engel - Tuesday Jun 20, 2017

    Localytics, one of Boston’s prominent mobile analytics and marketing software companies, has replaced its founding CEO Raj Aggarwal with Jude McColgan, a veteran mobile software executive. Aggarwal (pictured at right) will remain involved with the company, but his exact role is unclear. A spokeswoman says Aggarwal’s new role will be full-time and he will remain […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Harvard Biotech Spinout Lands $10M to Make Platelets From Stem Cells
    By Frank Vinluan - Thursday Jun 8, 2017

    If you’ve donated blood, you probably received a follow-up message asking you to consider a platelet donation. Donation centers must constantly replenish their blood supplies, but the need for platelets is particularly acute. Compared to other components of blood, platelets are fragile and short lived, which puts high demand on the small supply of these […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Sqrrl Sniffs Out $12.3M to Push “Threat Hunting” Software
    By Jeff Engel - Wednesday Jun 14, 2017

    Sqrrl has grabbed $12.3 million from investors to help drive more sales of its software that aims to detect cyber attackers. The Series C funding round was led by Spring Lake Equity Partners, whose partner Jeff Williams will join Sqrrl’s board. Other investors in the round include previous Sqrrl backers Matrix Partners, Rally Ventures, and […]

    Source: Xconomy VC, Deals, & Startups Feed